Recently, the biotech world has faced more venture funds coming from emerging markets than ever before. Together, Russia, China and India have all invested in global success stories with well-known venture funds.
Attendees will hear from experts as they ask the questions: What does this VC model look like? The funds might have big ambitions, high-level expertise and access to new lower-competition markets however should one cooperate with them and if so, how?
Session ID: 21929